Standout Papers
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status (2011)
- Quality Indicators for Colonoscopy and the Risk of Interval Cancer (2010)
- Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer (2006)
- Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia (2006)
Immediate Impact
1 by Nobel laureates 10 from Science/Nature 100 standout
Citing Papers
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
Targeting FAK in anticancer combination therapies
2021 Standout
Works of Marek P. Nowacki being referenced
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
2011 Standout
[Lymphography in the evaluation of various radical operations].
1969
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marek P. Nowacki | 5573 | 2617 | 2600 | 50 | 6.1k | |
| Harry S. Wieand | 6126 | 3001 | 2034 | 53 | 7.9k | |
| C. Topham | 5627 | 1542 | 1541 | 37 | 6.4k | |
| Philip R. Clingan | 4616 | 1274 | 1408 | 45 | 5.5k | |
| Arnaud Roth | 3334 | 1251 | 1798 | 115 | 5.0k | |
| R.D. James | 2896 | 2191 | 1577 | 59 | 4.5k | |
| Jean‐François Seitz | 4124 | 2733 | 2077 | 128 | 5.8k | |
| Florin Sirzén | 3491 | 1060 | 2567 | 28 | 5.4k | |
| Werner Hohenberger | 4841 | 3323 | 2081 | 178 | 6.4k | |
| Jorge Aparicio | 2932 | 1662 | 1391 | 147 | 4.2k | |
| Ronald L. Burkes | 4137 | 712 | 3625 | 93 | 5.8k |
All Works
Loading papers...